➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
McKinsey
Moodys
Harvard Business School
Dow

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Zabofloxacin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Zabofloxacin?

Zabofloxacin is an investigational drug.

There have been 4 clinical trials for Zabofloxacin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2012.

The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive, and Lung Diseases. The leading clinical trial sponsors are Dong Wha Pharmaceutical Co. Ltd., Bundang CHA Hospital, and Konyang University Hospital.

There are twenty-one US patents protecting this investigational drug and one hundred and forty-eight international patents.

Recent Clinical Trials for Zabofloxacin
TitleSponsorPhase
Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of ZabofloxacinDong Wha Pharmaceutical Co. Ltd.Phase 1
A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mgAjou UniversityPhase 3
A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mgAsan Medical CenterPhase 3

See all Zabofloxacin clinical trials

Clinical Trial Summary for Zabofloxacin

Top disease conditions for Zabofloxacin
Top clinical trial sponsors for Zabofloxacin

See all Zabofloxacin clinical trials

US Patents for Zabofloxacin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Zabofloxacin   Get Started Free Hamamelitannin analogues and uses thereof UNIVERSITEIT GENT (Ghent, BE)   Get Started Free
Zabofloxacin   Get Started Free Method for using novel hydroxamic acid derivative and antibacterial substance in combination TOYAMA CHEMICAL CO., LTD. (Shinjuku-ku, JP)   Get Started Free
Zabofloxacin   Get Started Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN)   Get Started Free
Zabofloxacin   Get Started Free Compounds and methods of treating infections NEOCULI PTY LTD (Victoria, AU)   Get Started Free
Zabofloxacin   Get Started Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Zabofloxacin

Drugname Country Document Number Estimated Expiration Related US Patent
Zabofloxacin European Patent Office EP3166955 2034-07-08   Get Started Free
Zabofloxacin World Intellectual Property Organization (WIPO) WO2016005340 2034-07-08   Get Started Free
Zabofloxacin Australia AU2015316400 2034-09-12   Get Started Free
Zabofloxacin Brazil BR112017004796 2034-09-12   Get Started Free
Zabofloxacin Canada CA2960936 2034-09-12   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Dow
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.